Annals of the rheumatic diseases, 2013-03, Vol.72 (3), p.464-465
2013
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis
- Ist Teil von
- Annals of the rheumatic diseases, 2013-03, Vol.72 (3), p.464-465
- Ort / Verlag
- England: BMJ Publishing Group Ltd and European League Against Rheumatism
- Erscheinungsjahr
- 2013
- Quelle
- BMJ Journals Archiv - DFG Nationallizenzen
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0003-4967eISSN: 1468-2060DOI: 10.1136/annrheumdis-2012-202156Titel-ID: cdi_proquest_miscellaneous_1285463905
- Format
- –
- Schlagworte
- Adult, Amyloidosis, Amyloidosis - complications, Amyloidosis - drug therapy, Anti-TNF, Antibodies, Monoclonal, Humanized - therapeutic use, Antirheumatic Agents - therapeutic use, DMARDs (biologic), DMARDs (synthetic), Female, Humans, Male, Middle Aged, Outcomes research, Rheumatic Diseases - complications, Rheumatic Diseases - drug therapy, Tumor Necrosis Factor-alpha - therapeutic use